<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ivimey-Cook ER</submitter><funding>Leverhulme Trust</funding><funding>Natural Environment Research Council</funding><pagination>e70131</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12419861</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(9)</volume><pubmed_abstract>Dietary restriction (DR) robustly increases lifespan across taxa. However, in humans, long-term DR is difficult to maintain, leading to the search for compounds that regulate metabolism and increase lifespan without reducing caloric intake. The magnitude of lifespan extension from two such compounds, rapamycin and metformin, remains inconclusive, particularly in vertebrates. Here, we conducted a meta-analysis comparing lifespan extension conferred by rapamycin and metformin to DR-mediated lifespan extension across vertebrates. We assessed whether these effects were sex- and, when considering DR, treatment-specific. In total, we analysed 911 effect sizes from 167 papers covering eight different vertebrate species. We find that DR robustly extends lifespan across log-response means and media</pubmed_abstract><journal>Aging cell</journal><pubmed_title>Rapamycin, Not Metformin, Mirrors Dietary Restriction-Driven Lifespan Extension in Vertebrates: A Meta-Analysis.</pubmed_title><pmcid>PMC12419861</pmcid><funding_grant_id>NERC NE/W001020/1</funding_grant_id><funding_grant_id>ECF-2022-214</funding_grant_id><funding_grant_id>ECF‐2022‐214</funding_grant_id><pubmed_authors>Maklakov AA</pubmed_authors><pubmed_authors>Ivimey-Cook ER</pubmed_authors><pubmed_authors>Sultanova Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Rapamycin, Not Metformin, Mirrors Dietary Restriction-Driven Lifespan Extension in Vertebrates: A Meta-Analysis.</name><description>Dietary restriction (DR) robustly increases lifespan across taxa. However, in humans, long-term DR is difficult to maintain, leading to the search for compounds that regulate metabolism and increase lifespan without reducing caloric intake. The magnitude of lifespan extension from two such compounds, rapamycin and metformin, remains inconclusive, particularly in vertebrates. Here, we conducted a meta-analysis comparing lifespan extension conferred by rapamycin and metformin to DR-mediated lifespan extension across vertebrates. We assessed whether these effects were sex- and, when considering DR, treatment-specific. In total, we analysed 911 effect sizes from 167 papers covering eight different vertebrate species. We find that DR robustly extends lifespan across log-response means and media</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-02T01:05:03.469Z</modification><creation>2026-05-24T03:07:08.53Z</creation></dates><accession>S-EPMC12419861</accession><cross_references><pubmed>40532901</pubmed><doi>10.1111/acel.70131</doi></cross_references></HashMap>